NR 507 Week 8 Pathophysiology Synthesis Paper Example

Synthesis: One Man on Hospital Day Nine, With a Sodium of 127, a Potassium of 3.1 and Legs That Will Not Lift Him, Explained From Alveolar Hypoxia Upward Through the Lung, the Right Heart, the Kidney and the Muscle

Student Name

College of Nursing, Chamberlain University

NR 507: Advanced Pathophysiology

Instructor Name

Month Day, Year

Synthesis: One Man on Hospital Day Nine, With a Sodium of 127, a Potassium of 3.1 and Legs That Will Not Lift Him, Explained From Alveolar Hypoxia Upward Through the Lung, the Right Heart, the Kidney and the Muscle

One Patient, Whole Paper

Mr. H., 66, is the patient from my Week 7 paper, whose severe COPD had led to a failing right ventricle. He has now been in hospital for nine days. He received intravenous furosemide for his edema and a course of systemic corticosteroids for a COPD exacerbation, and he has spent most of the nine days in bed or a chair. His edema has improved but not resolved. Today his laboratory values show sodium 127 mmol/L, potassium 3.1 mmol/L, bicarbonate 36 mmol/L and creatinine 1.2 mg/dL, up from 0.9 on admission. His PaCO2 has risen from 58 to 64 mm Hg. Physical therapy reports that he cannot rise from a chair without help, although he walked independently before admission.

This paper explains those findings as one connected problem. Every system enters because it explains part of this man's presentation, and material from earlier in the term appears only where it does that work.

Down to the Origin

The origin is alveolar hypoxia. Destruction and obstruction in his lungs produce ventilation-perfusion mismatch and chronic hypoxemia. Hypoxic vasoconstriction and vessel remodeling raise pulmonary vascular resistance, and his right ventricle, pumping against that resistance, has dilated and failed (Weitzenblum & Chaouat, 2009). Everything that follows in this paper traces back to that failing right ventricle and the reduced forward flow it produces.

Up Through the Kidney: Salt, Water and Sodium

Reduced output from the failing right heart, and the left ventricle underfilled behind it, reduces effective arterial blood volume, the volume the body's pressure sensors perceive as filling the arteries. The kidney responds as it does to any perceived loss of volume: it activates the renin-angiotensin-aldosterone system and retains sodium and water, and the reduced arterial filling stimulates release of antidiuretic hormone (ADH). The retained fluid expands the veins and tissues, where it appears as edema, but it does little to fill the arteries, so the stimulus continues.

His sodium of 127 mmol/L comes from this ADH. In Week 2, I explained a sodium of 121 in a man with a lung tumor producing ADH with no volume stimulus at all; that man was clinically euvolemic, with a high urine sodium. Mr. H. is different in a way that matters. His ADH is released for a reason the body considers valid, low effective arterial volume, and he is visibly fluid overloaded. His hyponatremia is hypervolemic, and it belongs to the same group as the dilutional hyponatremia of heart failure and cirrhosis rather than to the syndrome of inappropriate antidiuresis (Spasovski et al., 2014). The two sodium values look alike on paper; the mechanisms and the treatments do not.

Potassium and Bicarbonate: Two Hormones Pushing the Same Way

His potassium of 3.1 mmol/L has three contributors, and they act at the same site. Furosemide blocks sodium reabsorption in the loop of Henle, so more sodium reaches the collecting duct. There, the aldosterone released in response to low effective arterial volume increases sodium reabsorption through epithelial sodium channels, and the lumen becomes more negative, drawing potassium out into the urine. This is the same collecting duct mechanism I mapped in Week 5 for a woman with an aldosterone-producing adenoma, but here the aldosterone is secondary, driven by the heart failure and the diuretic rather than by a tumor. The corticosteroids add a third push, because at high doses they also act on mineralocorticoid receptors.

The same segment explains his rising bicarbonate, now 36 mmol/L. Aldosterone increases hydrogen ion secretion, and the loss of chloride and volume with diuresis makes it harder for the kidney to excrete bicarbonate. The result is a metabolic alkalosis added on top of the bicarbonate he already retained to compensate for chronic hypercapnia.

Back to the Lung: A Defense Undone

The alkalosis returns to the lung and makes his breathing worse. A higher blood bicarbonate reduces the drive to breathe that carbon dioxide normally provides, and his PaCO2 has risen from 58 to 64 mm Hg. Higher carbon dioxide and lower oxygen intensify pulmonary vasoconstriction, which raises the load on his right ventricle again. The treatment intended to relieve his right heart failure, diuresis, has through the kidney partly undone the ventilatory defense that was protecting it. This is the loop at the center of the case.

The Muscle: Two Stressors at Once

His weakness has two causes acting on the same fibers. The first is disuse. As I described in Week 1, unloading skeletal muscle lowers protein synthesis and increases breakdown, and a bed rest study of healthy people over 60 found measurable losses of leg lean tissue and strength within ten days (Kortebein et al., 2007). Mr. H. has had nine days mostly in bed or a chair. The second is the corticosteroid course, which increases muscle protein breakdown, particularly in the large proximal muscles used to rise from a chair. Hypokalemia adds a third, functional contribution by making muscle membranes harder to excite. The result is a man whose thighs have lost both size and responsiveness in nine days.

The muscle matters to his lungs too. His respiratory muscles are already working at a disadvantage against hyperinflated lungs, and weakness from disuse, steroids and low potassium reduces their reserve further.

Disease Against Defense

Laid out together, the case shows a pattern: nearly every abnormal value is either the disease or a defense against it, and several defenses are now causing harm. Sodium and water retention defend a perceived loss of arterial volume but produce edema and dilute the sodium. Aldosterone defends volume but wastes potassium and raises bicarbonate. Bicarbonate retention defended his pH against chronic hypercapnia but, pushed higher, now suppresses his breathing. Reduced activity spares his energy but costs him muscle.

A Conclusion That Explains

The conclusion is that Mr. H.'s day-nine findings are one problem with one origin: a failing right ventricle, driven by hypoxic lung disease, activating the kidney's volume defenses, whose side effects on sodium, potassium and acid-base balance are now feeding back into his breathing and his muscles. That explanation predicts what should help, and in what order. Correcting the potassium and chloride will ease the alkalosis and allow his ventilatory drive to recover. Oxygen, titrated carefully, acts at the origin by reducing pulmonary vasoconstriction. Water restriction, not saline, is the right approach to a hypervolemic hyponatremia. And getting him standing and walking every day, with physical therapy, will begin to reverse the disuse atrophy while it is still on the reversible side of the line.

References

Kortebein, P., Ferrando, A., Lombeida, J., Wolfe, R., & Evans, W. J. (2007). Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA, 297(16), 1772-1774. https://doi.org/10.1001/jama.297.16.1772-b

Spasovski, G., Vanholder, R., Allolio, B., Annane, D., Ball, S., Bichet, D., Decaux, G., Fenske, W., Hoorn, E. J., Ichai, C., Joannidis, M., Soupart, A., Zietse, R., Haller, M., van der Veer, S., Van Biesen, W., & Nagler, E. (2014). Clinical practice guideline on diagnosis and treatment of hyponatraemia. European Journal of Endocrinology, 170(3), G1-G47. https://doi.org/10.1530/EJE-13-1020

Weitzenblum, E., & Chaouat, A. (2009). Cor pulmonale. Chronic Respiratory Disease, 6(3), 177-185. https://doi.org/10.1177/1479972309104664